HEPATITIS Australia has today announced the national rollout of the HepLink hepatitis C telehealth service, a new telephone and virtual care service designed to make testing, treatment and support easier than ever.
Funded by the Australian Centre for Disease Control, the service provides information about hepatitis C testing, support to arrange blood tests, virtual clinical consultations, and fast access to prescriptions for curative treatment.
The launch comes as the organisation marks the 10th anniversary of the Pharmaceutical Benefits Scheme (PBS) listing of world-leading hepatitis C medicines in Mar 2016, which has helped almost 100,000 people beat the disease.
Hepatitis Australia CEO Lucy Clynes said the Federal Government's decision to provide broad, free access to hepatitis C cures was one of the most significant public health reforms in a generation.
"A decade ago, hepatitis C treatment was long, difficult and out of reach for many people - the PBS listing absolutely changed everything," Clynes said.
"Almost 100,000 people have been cured of a virus that can cause cirrhosis, liver failure and liver cancer."
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Mar 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Mar 26
